<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05112809</url>
  </required_header>
  <id_info>
    <org_study_id>21-007158</org_study_id>
    <nct_id>NCT05112809</nct_id>
  </id_info>
  <brief_title>Noninvasive Cochlear Stimulation System</brief_title>
  <official_title>Noninvasive Cochlear Stimulation System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to develop a portable wearable hardware headset using a&#xD;
      computer-based software that can establish the optimal stimulation parameters appropriate for&#xD;
      medical and consumer environments for individuals with hearing impaired and normal hearing&#xD;
      individuals.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perception threshold</measure>
    <time_frame>Baseline, approximately 2 hours</time_frame>
    <description>Evaluated by increasing the amplitude of the current input until the subject can hear a tone. The threshold will be recorded as the perception threshold at that electrode pair and frequency. Reported in hertz (Hz).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Speech Intelligibility</measure>
    <time_frame>Baseline, approximately 2 hours</time_frame>
    <description>Measured using the modified rhyme test (MRT) consisting of a set of 50 six-item wordlist. Each word list contains single syllable words with a consonant-vowel-consonant sound sequence.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Normal hearing subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with normal hearing will have a standard hearing test utilizing the cochlear stimulation system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bilateral hearing impaired</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with bilateral hearing impairment will have a standard hearing test utilizing the cochlear stimulation system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asymmetrical hearing-impaired</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with asymmetrical hearing-impairment will have a standard hearing test utilizing the cochlear stimulation system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cochlear Stimulation System (CSS)</intervention_name>
    <description>Cochlear stimulation with surround sound and noise cancellation</description>
    <arm_group_label>Asymmetrical hearing-impaired</arm_group_label>
    <arm_group_label>Bilateral hearing impaired</arm_group_label>
    <arm_group_label>Normal hearing subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Employee of Mayo Clinic.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant.&#xD;
&#xD;
          -  Cochlear implants.&#xD;
&#xD;
          -  History of fluctuating sensorineural hearing loss.&#xD;
&#xD;
          -  Skin diseases of the head.&#xD;
&#xD;
          -  History of acute paroxysmal tachycardia.&#xD;
&#xD;
          -  History of trigeminal neuralgia.&#xD;
&#xD;
          -  Recent of paralysis of the facial nerve.&#xD;
&#xD;
          -  Recent cerebrovascular stroke.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Cevette, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 28, 2021</study_first_submitted>
  <study_first_submitted_qc>October 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Michael Cevette</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Normal hearing</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

